Afatinib as first-line treatment for patients with advanced non-small-cell lung cancer harboring EGFR mutations: focus on LUX-Lung 3 and LUX-Lung 6 phase III trials

Por Passaro, Antonio, Gori, Bruno, de Marinis, Filippo
Publicado em 2013

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

Por Gori, Bruno, Ricciardi, Serena, Fulvi, Alberto, Intagliata, Salvatore, Signore, Ester Del, de Marinis, Filippo
Publicado em 2011

Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies

Por D’Antonio, Chiara, Passaro, Antonio, Gori, Bruno, Del Signore, Ester, Migliorino, Maria Rita, Ricciardi, Serena, Fulvi, Alberto, de Marinis, Filippo
Publicado em 2014